Henry Schein, Inc. 

(Public, NASDAQ:HSIC)   Watch this stock   
Find more results for HSIC
Nov 4, 2009
Q3 2009 Earnings Conference Call - Webcast
Nov 4, 2009
Q3 2009 Earnings Release
Sep 14, 2009
Morgan Stanley Global Healthcare Conference - Webcast
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 5.86% 4.19%
Operating margin 6.86% 6.56%
EBITD margin - 7.71%
Return on average assets 10.61% 7.75%
Return on average equity 18.36% 13.52%
Employees 12,500 -

Address

135 Duryea Road
Melville, NY 11747
United States - Map
+1-631-8435500 (Phone)
+1-631-8435658 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Henry Schein, Inc. discussed on blogs

Ranking 700+ Mid-Cap Stocks by Profit Margin - NASD100.com - Daily ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

Henry Schein, Inc. discussions

  View all discussions »

Description

Henry Schein, Inc. is a distributor of healthcare products and services to office-based healthcare practitioners in the combined North American and European markets. The Company serves more than 575,000 customers worldwide, including dental practitioners and laboratories, physician practices and animal health clinics, as well as government and other institutions. The Company conducts its business through two segments: healthcare distribution and technology. In November 2008, the Company discontinued its wholesale ultrasound business. In April 2008, it acquired Minerva Dental Limited (Minerva), a supplier of dental consumables and equipment in the United Kingdom. On December 23, 2008, it acquired DNA Anthos Impianti (DNA), Medka and Noviko. In March 2009, the Company acquired Ortho Organizers, a manufacturer and distributor of orthodontics products.

Officers and directors

Stanley M. Bergman
Chairman of the Board, Chief Executive Officer
Age: 59
Bio & Compensation - Reuters
James P. Breslawski
President, Chief Operating Officer, Director
Age: 55
Bio & Compensation - Reuters
Steven Paladino
Chief Financial Officer, Executive Vice President, Director
Age: 52
Bio & Compensation - Reuters
Michael Zack
President, International Group
Age: 56
Bio & Compensation - Reuters
Lonnie Shoff
President - Henry Schein Global Healthcare Specialties Group
Bio & Compensation - Reuters
Gerald A. Benjamin
Executive Vice President, Chief Administrative Officer, Director
Age: 56
Bio & Compensation - Reuters
Mark E. Mlotek
Executive Vice President - Corporate Business Development, Director
Age: 53
Bio & Compensation - Reuters
James Harding
Senior Vice President, Chief Technology Officer
Age: 53
Bio & Compensation - Reuters
Leonard A. David
Senior Vice President, Chief Compliance Officer
Age: 60
Bio & Compensation - Reuters
Michael Racioppi
Senior Vice President, Chief Merchandising Officer
Age: 54
Bio & Compensation - Reuters